207 related articles for article (PubMed ID: 2046028)
1. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428.
Scheffel U; Pögün S; Stathis M; Boja JW; Kuhar MJ
J Pharmacol Exp Ther; 1991 Jun; 257(3):954-8. PubMed ID: 2046028
[TBL] [Abstract][Full Text] [Related]
2. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
Boja JW; Rahman MA; Philip A; Lewin AH; Carroll FI; Kuhar MJ
Mol Pharmacol; 1991 Mar; 39(3):339-45. PubMed ID: 1826041
[TBL] [Abstract][Full Text] [Related]
3. Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency.
Cline EJ; Scheffel U; Boja JW; Carroll FI; Katz JL; Kuhar MJ
J Pharmacol Exp Ther; 1992 Mar; 260(3):1174-9. PubMed ID: 1545384
[TBL] [Abstract][Full Text] [Related]
4. [3H]WIN 35,428 ([3H]CFT) binds to multiple charge-states of the solubilized dopamine transporter in primate striatum.
Gracz LM; Madras BK
J Pharmacol Exp Ther; 1995 Jun; 273(3):1224-34. PubMed ID: 7791095
[TBL] [Abstract][Full Text] [Related]
5. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
[TBL] [Abstract][Full Text] [Related]
6. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex.
Boja JW; Carroll FI; Vaughan RA; Kopajtic T; Kuhar MJ
Synapse; 1998 Sep; 30(1):9-17. PubMed ID: 9704876
[TBL] [Abstract][Full Text] [Related]
7. Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites.
Ritz MC; George FR
J Pharmacol Exp Ther; 1993 Mar; 264(3):1333-43. PubMed ID: 8450469
[TBL] [Abstract][Full Text] [Related]
8. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims.
Staley JK; Hearn WL; Ruttenber AJ; Wetli CV; Mash DC
J Pharmacol Exp Ther; 1994 Dec; 271(3):1678-85. PubMed ID: 7996484
[TBL] [Abstract][Full Text] [Related]
9. Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter.
Houlihan WJ; Boja JW; Parrino VA; Kopajtic TA; Kuhar MJ
J Med Chem; 1996 Dec; 39(25):4935-41. PubMed ID: 8960553
[TBL] [Abstract][Full Text] [Related]
10. [3H]WIN 35,428 binding in the caudate nucleus of the rabbit: evidence for a single site on the dopamine transporter.
Aloyo VJ; Ruffin JS; Pazdalski PS; Kirifides AL; Harvey JA
J Pharmacol Exp Ther; 1995 Apr; 273(1):435-44. PubMed ID: 7714799
[TBL] [Abstract][Full Text] [Related]
11. Age-related reductions in [3H]WIN 35,428 binding to the dopamine transporter in nigrostriatal and mesolimbic brain regions of the fischer 344 rat.
Hebert MA; Larson GA; Zahniser NR; Gerhardt GA
J Pharmacol Exp Ther; 1999 Mar; 288(3):1334-9. PubMed ID: 10027875
[TBL] [Abstract][Full Text] [Related]
12. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
Kilbourn MR; Kuszpit K; Sherman P
Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
[TBL] [Abstract][Full Text] [Related]
13. Relationship between subjective effects of cocaine and dopamine transporter occupancy.
Volkow ND; Wang GJ; Fischman MW; Foltin RW; Fowler JS; Abumrad NN; Vitkun S; Logan J; Gatley SJ; Pappas N; Hitzemann R; Shea CE
Nature; 1997 Apr; 386(6627):827-30. PubMed ID: 9126740
[TBL] [Abstract][Full Text] [Related]
14. Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters.
Scheffel U; Steinert C; Kim SE; Ehlers MD; Boja JW; Kuhar MJ
Synapse; 1996 Jun; 23(2):61-9. PubMed ID: 8723710
[TBL] [Abstract][Full Text] [Related]
15. IPT: a novel iodinated ligand for the CNS dopamine transporter.
Kung MP; Essman WD; Frederick D; Meegalla S; Goodman M; Mu M; Lucki I; Kung HF
Synapse; 1995 Aug; 20(4):316-24. PubMed ID: 7482291
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, dopamine transporter affinity, dopamine uptake inhibition, and locomotor stimulant activity of 2-substituted 3 beta-phenyltropane derivatives.
Xu L; Kelkar SV; Lomenzo SA; Izenwasser S; Katz JL; Kline RH; Trudell ML
J Med Chem; 1997 Mar; 40(6):858-63. PubMed ID: 9083474
[TBL] [Abstract][Full Text] [Related]
17. WIN 35,428 and mazindol are mutually exclusive in binding to the cloned human dopamine transporter.
Xu C; Reith ME
J Pharmacol Exp Ther; 1997 Aug; 282(2):920-7. PubMed ID: 9262359
[TBL] [Abstract][Full Text] [Related]
18. Non-amine dopamine transporter probe [(3)H]tropoxene distributes to dopamine-rich regions of monkey brain.
De La Garza R; Meltzer PC; Madras BK
Synapse; 1999 Oct; 34(1):20-7. PubMed ID: 10459168
[TBL] [Abstract][Full Text] [Related]
19. Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.
Agoston GE; Wu JH; Izenwasser S; George C; Katz J; Kline RH; Newman AH
J Med Chem; 1997 Dec; 40(26):4329-39. PubMed ID: 9435902
[TBL] [Abstract][Full Text] [Related]
20. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum.
Kaufman MJ; Madras BK
Synapse; 1991 Sep; 9(1):43-9. PubMed ID: 1796351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
